Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down
Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.
Gross proceeds to Tonix from this offering are $8,010,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Tonix. Aegis Capital Corp. acted as the sole book-running manager for the offering and Dawson James Securities, Inc. acted as a co-manager.
The Sichenzia Ross Ference Kesner LLP team was led by Partners Marc J. Ross and James M. Turner.
- Sichenzia Ross Ference LLP任命Andrew Bernstein为合伙人，领导白领刑事辩护业务 - May 4, 2020
- Sichenzia Ross Ference LLP代表Aegis Capital进行Avinger，Inc.的315万美元公开发行 - April 30, 2020
- 60天并不断增长：“最佳监管”即将到来。准备好独立经纪交易商了吗？他们需要知道和做什么 - April 29, 2020